Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-614.90	-86.94	-12.16
Graham Fair Price	168.71	0.17	0.06
PEG	-65.91	< 0.005	0.03
Price/Book	-80.13	-0.24	1.21
Price/Cash Flow	-56.19	6.71	15.32
Prices/Earnings	64.14	-0.91	-2.52
Price/Sales	-64.14	1.23	3.43
Price/FCF	-56.19	6.71	15.32
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.25	0.25
Operating Margin	0.00	-0.63	-0.63
ROA	-100.00	-0.03	-0.01
ROE	-0.12	0.07	-44.58
ROIC	-0.10	-0.12	-28.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	3.00	-0.39	677.34
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.58	-1.00	72.71
EPS QOQ	0.93	-0.98	5.22
FCF QOQ	-0.79	0.64	-19.43
Revenue QOQ	-0.61	1.00	64.76
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1231.14	615.57	-50.00
Days Sales Outstanding (DSO)	23.66	117.76	397.65
Inventory Turnover	0.07	0.15	100.00
Debt/Capitalization	0.63	2.15	242.04
Quick Ratio	0.14	0.31	121.09
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.04	-0.14	260.96
Cash	0.03	0.04	32.51
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	63.74
Revenue	0.01	0.03	100.03
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.87	0.87	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.40	-75.59	-1300.13
Naive Interpretation	Member

06 - Financial Health · Bad

Rating